Compile Data Set for Download or QSAR
Report error Found 229 for UniProtKB: Q91132
TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251408BDBM251408(US9452990, 90)
Affinity DataIC50: 1nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251420BDBM251420(US9452990, 102)
Affinity DataIC50: 1nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251449BDBM251449(US9452990, 131)
Affinity DataIC50: 3nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251413BDBM251413(US9452990, 95)
Affinity DataIC50: 3nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251397BDBM251397(US9452990, 77)
Affinity DataIC50: 4nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251411BDBM251411(US9452990, 93)
Affinity DataIC50: 4nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251348BDBM251348(US9452990, 28)
Affinity DataIC50: 5nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251330BDBM251330(US9452990, 10)
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251345BDBM251345(US9452990, 25)
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251402BDBM251402(US9452990, 84)
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251416BDBM251416(US9452990, 98)
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251417BDBM251417(US9452990, 99)
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251451BDBM251451(US9452990, 80)
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251412BDBM251412(US9452990, 94)
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251389BDBM251389(US9452990, 69)
Affinity DataIC50: 7nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251384BDBM251384(US9452990, 64)
Affinity DataIC50: 7nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251410BDBM251410(US9452990, 92)
Affinity DataIC50: 8nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251378BDBM251378(US9452990, 58)
Affinity DataIC50: 9nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251448BDBM251448(US9452990, 130)
Affinity DataIC50: 10nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251387BDBM251387(US9452990, 67)
Affinity DataIC50: 10nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251414BDBM251414(US9452990, 96)
Affinity DataIC50: 10nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251364BDBM251364(US9452990, 44)
Affinity DataIC50: 10nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251346BDBM251346(US9452990, 26)
Affinity DataIC50: 11nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251328BDBM251328(US9452990, 8)
Affinity DataIC50: 11nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251415BDBM251415(US9452990, 97)
Affinity DataIC50: 11nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251409BDBM251409(US9452990, 91)
Affinity DataIC50: 12nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251419BDBM251419(US9452990, 101)
Affinity DataIC50: 13nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251349BDBM251349(US9452990, 29)
Affinity DataIC50: 14nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251343BDBM251343(US9452990, 23)
Affinity DataIC50: 15nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251421BDBM251421(US9452990, 103)
Affinity DataIC50: 15nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251322BDBM251322(US9452990, 2)
Affinity DataIC50: 16nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251342BDBM251342(US9452990, 22)
Affinity DataIC50: 17nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251329BDBM251329(US9452990, 9)
Affinity DataIC50: 20nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251439BDBM251439(US9452990, 121)
Affinity DataIC50: 20nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251327BDBM251327(US9452990, 7)
Affinity DataIC50: 20nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251418BDBM251418(US9452990, 100)
Affinity DataIC50: 20nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251338BDBM251338(US9452990, 18)
Affinity DataIC50: 20nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251380BDBM251380(US9452990, 60)
Affinity DataIC50: 20nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251406BDBM251406(US9452990, 88)
Affinity DataIC50: 30nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251407BDBM251407(US9452990, 89)
Affinity DataIC50: 30nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251401BDBM251401(US9452990, 83)
Affinity DataIC50: 30nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251385BDBM251385(US9452990, 65)
Affinity DataIC50: 30nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251363BDBM251363(US9452990, 43)
Affinity DataIC50: 40nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251404BDBM251404(US9452990, 86)
Affinity DataIC50: 40nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251405BDBM251405(US9452990, 87)
Affinity DataIC50: 40nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251357BDBM251357(US9452990, 37)
Affinity DataIC50: 40nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251366BDBM251366(US9452990, 46)
Affinity DataIC50: 40nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251381BDBM251381(US9452990, 61)
Affinity DataIC50: 40nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251394BDBM251394(US9452990, 74)
Affinity DataIC50: 50nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251373BDBM251373(US9452990, 53)
Affinity DataIC50: 50nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

Displayed 1 to 50 (of 229 total ) | Next | Last >>
Jump to: